SEC Form 4 · accession 0001185185-16-005492
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kristin C Comella
Officer — Chief Scientific Officer · Director
Period of report
Sep 19, 2016
Accepted (ET)
Sep 23, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.0196 | Sep 19, 2016 | A | 5,000,000 | A | — | Sep 19, 2026 | Common Stock | 5,000,000 | 5,197,748 | D |
| Stock Options (right to buy) | $0.0196 | Sep 19, 2016 | A | 1,500,000 | A | Sep 19, 2016 | Sep 19, 2026 | Common Stock | 1,500,000 | 6,697,748 | D |
Explanation of responses
- F11,250,000 vest on 09/19/2017, 1,250,000 vest on 09/19/2018, 1,250,000 vest on 09/19/2019, 1,250,000 vest on 09/19/2020